Home
Coverage
Amryt
Anixa Biosciences
Aptose
Atomera
Fortress Bio
Harrow
INmune Bio
Lantern Pharma
LexaGene
ParkerVision
Quest Resource Holding
Sequans
Summit Wireless
TFF Pharmaceuticals
Members
Current Holdings & Performance
Trading Blog
Zoom Calls…
Newsletter
Monthly Performance Reviews
Weekly Newsletters
About
About
Contact Us
Privacy Policy
Disclaimer
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Member Login
Login
Reset Password
Become a Member
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
TW Research Group
Home
Coverage
Amryt
Anixa Biosciences
Aptose
Atomera
Fortress Bio
Harrow
INmune Bio
Lantern Pharma
LexaGene
ParkerVision
Quest Resource Holding
Sequans
Summit Wireless
TFF Pharmaceuticals
Members
Current Holdings & Performance
Trading Blog
Zoom Calls…
Newsletter
Monthly Performance Reviews
Weekly Newsletters
About
About
Contact Us
Privacy Policy
Disclaimer
Daniel Carlson
1652 POSTS
412 COMMENTS
Front Page
In Defense of INmune
Daniel Carlson
-
April 10, 2021
5
Front Page
First U.S. Patent Issues on Hancock Jaffe VenoValve
Daniel Carlson
-
April 7, 2021
0
Front Page
Sequans Announces $50 Million Financing to Strengthen Balance Sheet
Daniel Carlson
-
April 7, 2021
0
Front Page
Lithe Audio Launches First WiSA Certified Dolby Atmos Ceiling Speakers
Daniel Carlson
-
April 7, 2021
0
Amryt
Amryt Announces the Appointment of Sheila Frame as President Americas
Daniel Carlson
-
April 6, 2021
0
Front Page
Trading Blog, April 6, 2021
Daniel Carlson
-
April 6, 2021
0
Anixa
Anixa Biosciences and OntoChem Enter Next Stage of Development for Covid-19...
Daniel Carlson
-
April 5, 2021
0
Front Page
Hancock Jaffe Receives IDE Approval To Begin VenoValve U.S. Pivotal Trial
Daniel Carlson
-
April 5, 2021
0
Amryt
A Catalyst Filled Quarter Lies Around The Corner
Daniel Carlson
-
April 3, 2021
6
Fortress Bio
Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc.,...
Daniel Carlson
-
April 1, 2021
0
Front Page
LEXAGENE PROVIDES CORPORATE UPDATE
Daniel Carlson
-
April 1, 2021
0
Front Page
Lantern Pharma Expands Portfolio of Cancer Opportunities for LP-184 with ATRT...
Daniel Carlson
-
April 1, 2021
0
Amryt
Amryt Submits a New Drug Application to the US Food and...
Daniel Carlson
-
March 31, 2021
0
Amryt
Amryt Announces Results from an Investigator Sponsored Study of Lomitapide in...
Daniel Carlson
-
March 30, 2021
0
Front Page
Orlando Court to Reschedule Trial; Company Raises $3.6 Million in Private...
Daniel Carlson
-
March 29, 2021
0
Amryt
Amryt Announces Validation of its MAA by the EMA for Oleogel-S10*...
Daniel Carlson
-
March 29, 2021
0
Anixa
2nd Degree of Risk
Daniel Carlson
-
March 27, 2021
3
Front Page
TFF Pharmaceuticals Prices Offering of Common Stock
Daniel Carlson
-
March 26, 2021
0
Anixa
This Week’s View On Anixa
Daniel Carlson
-
March 25, 2021
6
Uncategorized
Anixa Biosciences Increases Previously Announced Bought Deal Offering of Common Stock...
Daniel Carlson
-
March 23, 2021
0
Front Page
WiSA Member Foxconn Demos Sharp 120-Inch 8K TV with WiSA SoundSend...
Daniel Carlson
-
March 23, 2021
5
Amryt
Amryt Receives Positive Feedback from the FDA on the Path Forward...
Daniel Carlson
-
March 23, 2021
0
Front Page
Lantern Pharma to Present New Data Supporting the Advancement of LP-184...
Daniel Carlson
-
March 23, 2021
0
Anixa
Anixa Biosciences and Moffitt Cancer Center File IND Application for Ovarian...
Daniel Carlson
-
March 22, 2021
4
Amryt
Amryt Receives Reimbursement Approval from the French Ministry of Social Affairs...
Daniel Carlson
-
March 22, 2021
0
Anixa
Sitting On My Hands
Daniel Carlson
-
March 20, 2021
3
Front Page
Hisense TVs Certified WiSA Ready™, WiSA’s Interoperability Standard Becoming Must-Have Feature...
Daniel Carlson
-
March 18, 2021
0
Front Page
Lantern Pharma Announces Filing of Seven Patent Applications Globally on Novel...
Daniel Carlson
-
March 17, 2021
0
Anixa
Technically Speaking
Daniel Carlson
-
March 13, 2021
11
Front Page
Recapping TFF’s Shareholder Update Call
Daniel Carlson
-
March 12, 2021
3
Front Page
QUEST RESOURCE HOLDING CORPORATION REPORTS 2020 FINANCIAL RESULTS
Daniel Carlson
-
March 12, 2021
0
Anixa
Anixa Biosciences Announces Issuance and Publication of European Patent for Ovarian...
Daniel Carlson
-
March 12, 2021
0
Front Page
Platin Audio Debuts Sleek and Powerful New Product Line for Home...
Daniel Carlson
-
March 11, 2021
0
Front Page
TFF Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial and...
Daniel Carlson
-
March 10, 2021
0
Front Page
Lantern Pharma Reports Fourth Quarter and Year End 2020 Financial Results...
Daniel Carlson
-
March 10, 2021
0
Front Page
NeuroRX and TFF Pharmaceuticals Announce Entering Into Feasibility Collaboration
Daniel Carlson
-
March 9, 2021
0
Front Page
Feasibility Arrangement for shelf-stable powder form of messenger RNA COVID-19 Vaccine...
Daniel Carlson
-
March 9, 2021
0
Front Page
Harrow Health Announces Fourth Quarter and Year-End 2020 Financial Results
Daniel Carlson
-
March 8, 2021
0
Amryt
Amryt and Medison Pharma Sign Distribution Agreement for Myalepta® (metreleptin) in...
Daniel Carlson
-
March 8, 2021
0
Amryt
Blood In The Water
Daniel Carlson
-
March 6, 2021
0
Front Page
Trading Blog, March 5, 2021
Daniel Carlson
-
March 5, 2021
3
Anixa
Anixa Biosciences Announces European Patent Issued for its CAR-T Cancer Therapy
Daniel Carlson
-
March 4, 2021
0
Front Page
TFF Pharmaceuticals Provides Update on Clinical Development Programs
Daniel Carlson
-
March 4, 2021
0
Amryt
Amryt (AMYT): A Rare Find in Today’s Market… Growth At A...
Daniel Carlson
-
March 2, 2021
4
Front Page
LEXAGENE RECEIVES $3.6M FROM THE EXERCISE OF WARRANTS
Daniel Carlson
-
March 2, 2021
0
Atomera
Atomera, Inc: Atomera Announces First Customer to Enter Phase 4
Daniel Carlson
-
March 2, 2021
0
Front Page
Keep Looking Forward
Daniel Carlson
-
February 27, 2021
3
Fortress Bio
Aevitas Therapeutics Appoints Markus Peters, Ph.D., M.Sc., as Chief Executive Officer
Daniel Carlson
-
February 25, 2021
0
Front Page
Trading Blog, Feb. 25th 2021
Daniel Carlson
-
February 25, 2021
4
Fortress Bio
Cyprium Therapeutics, a Fortress Biotech Partner Company, and Sentynl Therapeutics, a...
Daniel Carlson
-
February 24, 2021
0
Front Page
Miami Advice
Daniel Carlson
-
February 20, 2021
7
Front Page
TFF Pharmaceuticals Announces Positive Preclinical Results with Two Biodefense Countermeasures for...
Daniel Carlson
-
February 19, 2021
0
Front Page
Trading Blog, Feb. 18th, 2021
Daniel Carlson
-
February 16, 2021
1
Anixa
Anixa Biosciences Begins Animal Testing of Covid-19 Therapeutic Candidates
Daniel Carlson
-
February 16, 2021
0
Anixa
Heard On The Street
Daniel Carlson
-
February 13, 2021
10
Front Page
LexaGene Announces Change in Management and Appoints New Member to the...
Daniel Carlson
-
February 12, 2021
0
Front Page
HJLI Tried To Ruin 2019 For Me…2021 Should Be A Different...
Daniel Carlson
-
February 10, 2021
10
Atomera
Atomera Provides Fourth Quarter and Fiscal 2020 Results
Daniel Carlson
-
February 10, 2021
0
Front Page
LEXAGENE’S MIQLAB SUCCESSFULLY DETECTS MUTANT UK AND SOUTH AFRICAN COVID-19 SEQUENCES
Daniel Carlson
-
February 10, 2021
0
Front Page
Sequans Communications Announces Fourth Quarter 2020 and Full Year 2020 Financial...
Daniel Carlson
-
February 10, 2021
0
Anixa
Riding the Waves
Daniel Carlson
-
February 6, 2021
4
INmune
Trading Blog: INmune (INMB) and Cassava (SAVA)
Daniel Carlson
-
February 2, 2021
2
Fortress Bio
Mustang Bio Provides Updates on its Lentiviral Gene Therapies for the...
Daniel Carlson
-
February 2, 2021
0
Anixa
The GameStop Impact…January In Review
Daniel Carlson
-
January 30, 2021
8
Front Page
Sequans Receives Major Funding Award for 5G Development From French Government
Daniel Carlson
-
January 28, 2021
0
Front Page
ParkerVision Gets Inside Track On Intel In Markman Ruling
Daniel Carlson
-
January 27, 2021
5
Front Page
Trading Blog, Jan. 26, 2021
Daniel Carlson
-
January 27, 2021
0
Front Page
Texas Court’s Markman Ruling Favorable for ParkerVision
Daniel Carlson
-
January 27, 2021
0
Aptose
When Will The Music Stop?
Daniel Carlson
-
January 23, 2021
12
Front Page
INmune…Meaningful Progress in Alzheimer’s Disease
Daniel Carlson
-
January 21, 2021
12
Front Page
INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration...
Daniel Carlson
-
January 21, 2021
0
Front Page
Trade Alert, January 20, 2020
Daniel Carlson
-
January 20, 2021
1
Atomera
Next Up? INmune’s Big Week Finally Arrives
Daniel Carlson
-
January 16, 2021
7
Front Page
Lantern Pharma Announces Pricing of $60 Million Public Offering
Daniel Carlson
-
January 15, 2021
0
Front Page
Summit Wireless Technologies Reports Record Preliminary Revenue of $1.0 Million in...
Daniel Carlson
-
January 14, 2021
0
Front Page
LLY’s $20 Billion Bonanza Bodes Well For INMB
Daniel Carlson
-
January 13, 2021
2
Front Page
Provention Bio Announces Pricing of $100 Million Public Offering of Common...
Daniel Carlson
-
January 13, 2021
0
Front Page
LEXAGENE INITIATES PROGRAM TO IDENTIFY UK AND SOUTH AFRICAN COVID SEQUENCES
Daniel Carlson
-
January 13, 2021
0
Front Page
INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday,...
Daniel Carlson
-
January 13, 2021
0
Front Page
Trading Blog, Jan. 12, 2021
Daniel Carlson
-
January 12, 2021
0
Front Page
Muscle Maker Grill Opens Second Ghost Kitchen Location in Philadelphia
Daniel Carlson
-
January 12, 2021
2
Front Page
WiSA Wave Marketing Program Results in Record Consumer Traffic and is...
Daniel Carlson
-
January 12, 2021
0
Anixa
BOOM…Atomera Deal Highlights Another Bull Ride In The Market
Daniel Carlson
-
January 9, 2021
5
Front Page
Renesas and Sequans Expand Their 5G Collaboration Broadband IoT Module for...
Daniel Carlson
-
January 8, 2021
0
Front Page
First Complete Home Cinema Bundles with Hisense TVs, WiSA SoundSend Wireless...
Daniel Carlson
-
January 8, 2021
0
Atomera
ATOM: FOMO Kept Me From Selling, But Is It A Buy?
Daniel Carlson
-
January 7, 2021
5
Front Page
Trading Blog, January 7, 2021
Daniel Carlson
-
January 7, 2021
0
Front Page
Summit Wireless Technologies Launches the First Low-cost IoT Module to Support...
Daniel Carlson
-
January 6, 2021
0
Atomera
Atomera Inks First JDA
Daniel Carlson
-
January 5, 2021
3
Front Page
Lantern Pharma Announces Launch of Antibody Drug Conjugate (ADC) Program to...
Daniel Carlson
-
January 4, 2021
0
Front Page
Provention Bio Announces U.S. FDA Filing of a Biologics License Application...
Daniel Carlson
-
January 4, 2021
0
Front Page
TW’s Top Ten For 2021
Daniel Carlson
-
January 1, 2021
12
Front Page
Muscle Maker Grill Opens the Doors to Their First Ghost Kitchen...
Daniel Carlson
-
January 1, 2021
0
Front Page
Premium Subscriber Trade Alert, December 31, 2020
Daniel Carlson
-
January 1, 2021
2
Front Page
LEXAGENE STARTS FDA EUA STUDY FOR POINT-OF-CARE COVID-19 TESTING
Daniel Carlson
-
December 30, 2020
2
Anixa
Ho Ho Ho, Santa Rally Caps Bizarre Year
Daniel Carlson
-
December 26, 2020
7
Front Page
Trading Blog, December 21, 2020
Daniel Carlson
-
December 21, 2020
1
Fortress Bio
Mustang Bio and City of Hope Announce Initiation of Phase 1...
Daniel Carlson
-
December 21, 2020
0
Anixa
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical...
Daniel Carlson
-
December 21, 2020
0
Atomera
The Squeeze Is On
Daniel Carlson
-
December 18, 2020
3
Front Page
Trading Blog, December 18, 2020
Daniel Carlson
-
December 18, 2020
0
Front Page
Put LP-184, a Potential Blockbuster in the Making, on Your Radar...
Daniel Carlson
-
December 18, 2020
0
Front Page
LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency...
Daniel Carlson
-
December 17, 2020
0
Front Page
Lantern Pharma Announces Collaboration with World Leading Brain Cancer Program at...
Daniel Carlson
-
December 17, 2020
0
Fortress Bio
Avenue Therapeutics Provides Regulatory Update for IV Tramadol
Daniel Carlson
-
December 17, 2020
2
Fortress Bio
Fortress Biotech Announces Breakthrough Therapy Designation for CUTX-101, Copper Histidinate, for...
Daniel Carlson
-
December 15, 2020
0
Front Page
TFF Pharmaceuticals Announces First Dosing of Asthma Patients with Voriconazole Inhalation...
Daniel Carlson
-
December 15, 2020
0
Front Page
LexaGene Receives Purchase Order for MiQLab from Ethos Discovery
Daniel Carlson
-
December 15, 2020
2
Front Page
Lantern Pharma Announces Scientific & Preclinical Data Indicating Blood Brain Barrier...
Daniel Carlson
-
December 15, 2020
0
Front Page
Trade Alert, Dec. 14th, 2020
Daniel Carlson
-
December 14, 2020
0
Anixa
Anixa Biosciences Covid-19 Therapy Demonstrates Comparable Potency to Remdesivir in Pre-Clinical...
Daniel Carlson
-
December 14, 2020
1
Fortress Bio
Mustang Bio Announces Interim Phase 1/2 Data for MB-106 in Patients...
Daniel Carlson
-
December 12, 2020
0
Front Page
Changes at TW
Daniel Carlson
-
December 12, 2020
0
Anixa
Climbing The Wall Of Worry…
Daniel Carlson
-
December 12, 2020
4
Front Page
Sequans’ Monarch Module supported by Orange LTE-M Connectivity Now Available
Daniel Carlson
-
December 10, 2020
0
Front Page
Muscle Maker Grill Opens First Partnership Location with REEF Neighborhood Kitchens...
Daniel Carlson
-
December 9, 2020
0
Front Page
JDRF Launches First Mass Screening Program for Early-Stage Type 1 Diabetes...
Daniel Carlson
-
December 8, 2020
0
Atomera
Atomera Announces Availability of MSTcad for Modeling Semiconductor Device Improvements with...
Daniel Carlson
-
December 8, 2020
0
Front Page
SQNS Announces Pricing of Public Secondary Offering of American Depositary Shares
Daniel Carlson
-
December 8, 2020
0
Aptose
Aptose Presents Highlights from ASH and Corporate Update Event
Daniel Carlson
-
December 6, 2020
0
Anixa
The Micro-Cap Rally Continues Full Force
Daniel Carlson
-
December 5, 2020
0
Front Page
Study on Patented Non-Opioid MKO Melt® Reported in Leading Peer-Reviewed Anesthesia...
Daniel Carlson
-
December 3, 2020
0
Aptose
Timing Looks Good For Owning Aptose (APTO)
Daniel Carlson
-
December 3, 2020
0
Anixa
Anixa Adds An Ovarian Cancer Vaccine To Their Portfolio
Daniel Carlson
-
December 1, 2020
0
Anixa
Anixa Biosciences Announces Licensing Agreement with Cleveland Clinic for Ovarian Cancer...
Daniel Carlson
-
December 1, 2020
0
Front Page
WiSA’s First Branded Product, SoundSend, Now Available for WiSA Partners, Distributors...
Daniel Carlson
-
November 30, 2020
4
Anixa
Timing Is Everything…Or Is It?
Daniel Carlson
-
November 28, 2020
3
Fortress Bio
Mustang Bio Announces Positive Opinion from the European Medicines Agency on...
Daniel Carlson
-
November 24, 2020
0
Anixa
Anixa Biosciences and Cleveland Clinic File IND Application for Breast Cancer...
Daniel Carlson
-
November 23, 2020
0
Fortress Bio
Mustang Bio and Minaris Regenerative Medicine Sign Technology Transfer and GMP...
Daniel Carlson
-
November 23, 2020
0
Front Page
A Micro Thanksgiving
Daniel Carlson
-
November 21, 2020
2
Front Page
Trading Ideas Heading Towards Year-End
Daniel Carlson
-
November 19, 2020
0
Front Page
LEXAGENE PLACES MIQLAB SYSTEM AT THE UNIVERSITY OF PENNSYLVANIA’S SCHOOL OF...
Daniel Carlson
-
November 18, 2020
0
Front Page
Lantern Pharma Earnings Call Transcript
Daniel Carlson
-
November 17, 2020
0
Uncategorized
QUEST RESOURCE HOLDING REPORTS THIRD QUARTER 2020 FINANCIAL RESULTS
Daniel Carlson
-
November 16, 2020
0
Front Page
Processa Pharmaceuticas Transcript
Daniel Carlson
-
November 16, 2020
0
Front Page
LEXAGENE RECEIVES PURCHASE ORDER FROM A MULTINATIONAL BIOTECHNOLOGY COMPANY
Daniel Carlson
-
November 16, 2020
0
Anixa
The Biden Rally
Daniel Carlson
-
November 14, 2020
2
Front Page
Harrow Health Third Quarter 2020 Letter to Stockholders
Daniel Carlson
-
November 10, 2020
0
Dyadic
Pfizer Develops a Vaccine…Implications for Tailwinds
Daniel Carlson
-
November 10, 2020
5
Front Page
ParkerVision Files Against Zyxel and Buffalo for Patent Infringement
Daniel Carlson
-
November 10, 2020
0
Front Page
Summit Wireless Technologies Gains Momentum and Provides Third Quarter 2020 Update
Daniel Carlson
-
November 10, 2020
0
Fortress Bio
Checkpoint Therapeutics Announces Presentation of Updated Cosibelimab Lung Cancer Results at...
Daniel Carlson
-
November 9, 2020
0
Front Page
INmune Bio, Inc. Announces First Patient Dosed in Phase 2 Trial...
Daniel Carlson
-
November 9, 2020
0
Fortress Bio
Moving Week
Daniel Carlson
-
November 7, 2020
3
Front Page
TFFP, INMB, OTRK…Earnings Logjam At Tailwinds
Daniel Carlson
-
November 6, 2020
2
Front Page
INmune Bio, Inc. Announces Third Quarter Results and Provides Business Update
Daniel Carlson
-
November 5, 2020
0
Front Page
TFF Pharmaceuticals Reports Third Quarter 2020 Financial and Business Results
Daniel Carlson
-
November 5, 2020
0
Front Page
TFF Pharmaceuticals and Felix Biotechnology Sign Letter of Intent for a...
Daniel Carlson
-
November 5, 2020
0
Front Page
WiSA Association Expands TV Brand Member List With Rapidly Growing Hisense
Daniel Carlson
-
November 5, 2020
0
Fortress Bio
Mustang Bio Announces MB-106 Data Selected for Presentation at the 62nd...
Daniel Carlson
-
November 4, 2020
0
Front Page
Provention Bio Completes Rolling Submission of the Biologics License Application (BLA)...
Daniel Carlson
-
November 2, 2020
2
Front Page
TFF Pharmaceuticals, Inc. and Augmenta Bioworks, Inc. Enter Into a Worldwide...
Daniel Carlson
-
November 2, 2020
0
Anixa
Sell Mortimer, Sell!!!
Daniel Carlson
-
October 31, 2020
13
Atomera
Atomera Provides Third Quarter 2020 Results
Daniel Carlson
-
October 29, 2020
0
Front Page
Lantern Pharma Reports Third Quarter 2020 Financial Results & Continued Operational...
Daniel Carlson
-
October 29, 2020
0
Front Page
Buoyed by the Boom in New Home Theaters, WiSA Member Platin...
Daniel Carlson
-
October 28, 2020
0
Anixa
Anixa Biosciences to Host Conference Call to Provide Update on Programs
Daniel Carlson
-
October 27, 2020
4
Front Page
Muscle Maker Grill Adds Three New Ghost Kitchen Markets
Daniel Carlson
-
October 27, 2020
0
Front Page
Sequans Communications Announces Third Quarter 2020 Financial Results
Daniel Carlson
-
October 27, 2020
0
Front Page
TFF Pharmaceuticals Announces Positive Preclinical Results with University of Georgia Universal...
Daniel Carlson
-
October 27, 2020
2
Fortress Bio
Mustang Bio Announces Initial Phase 1 Data on MB-105 for Patients...
Daniel Carlson
-
October 26, 2020
0
Front Page
TFF Pharmaceuticals Expands its cGMP Manufacturing Capabilities with Experic
Daniel Carlson
-
October 26, 2020
2
Cabral Gold
Time for Small Cap to Shine?
Daniel Carlson
-
October 24, 2020
2
Front Page
Muscle Maker Grill Acquires Manhattan Location
Daniel Carlson
-
October 23, 2020
0
Front Page
Pharmaceutics: Development of Remdesivir as a Dry Powder for Inhalation by...
Daniel Carlson
-
October 23, 2020
0
Front Page
Muscle Maker Grill Signs Agreement Bringing Ghost Kitchens to Miami Beach,...
Daniel Carlson
-
October 22, 2020
0
Front Page
Renesas and Sequans to Collaborate on 5G/4G Cellular IoT
Daniel Carlson
-
October 22, 2020
0
Front Page
Muscle Maker Grill Awarded Contract for Two Locations on Navy Base
Daniel Carlson
-
October 21, 2020
0
Front Page
TFF Firing on All Cylinders; An Update on TAC and CBD
Daniel Carlson
-
October 21, 2020
0
Front Page
QUEST RESOURCE HOLDING CORPORATION ACQUIRES GREEN REMEDIES, STRENGTHENING PRESENCE IN STRATEGIC...
Daniel Carlson
-
October 20, 2020
0
Front Page
TFF Pharmaceuticals Updates Progress of Human Clinical Trial with Tacrolimus Inhalation...
Daniel Carlson
-
October 20, 2020
0
Cabral Gold
CABRAL GOLD IDENTIFIES NEW HIGH-GRADE TARGET AND PROVIDES RESULTS ON THE...
Daniel Carlson
-
October 20, 2020
0
Anixa
Post Traumatic Investment Disease Redux? Nah, Just A Dose Of Reality
Daniel Carlson
-
October 17, 2020
4
Front Page
Muscle Maker Grill Provides Shareholder Update
Daniel Carlson
-
October 15, 2020
0
Front Page
Trade Alert, October 12, 2020
Daniel Carlson
-
October 12, 2020
3
Dyadic
Dyadic Updates Market on COVID-19 Initiatives
Daniel Carlson
-
October 12, 2020
0
Fortress Bio
Avenue Therapeutics Receives Complete Response Letter from the FDA for IV...
Daniel Carlson
-
October 12, 2020
0
Anixa
This Week In Moab
Daniel Carlson
-
October 9, 2020
1
Front Page
Consumer Interest in WiSA Continues its Strong Upward Trajectory
Daniel Carlson
-
October 8, 2020
0
Fortress Bio
Mustang Bio Announces MB-105 Data Selected for Presentation at the Virtual...
Daniel Carlson
-
October 8, 2020
0
Front Page
Muscle Maker Grill Announces Opening of Healthy Joe’s in NYC
Daniel Carlson
-
October 7, 2020
0
Front Page
Telit and Sequans Partner to Launch New CBRS Modules
Daniel Carlson
-
October 5, 2020
0
Front Page
Lantern Pharma Advances Prostate Cancer Drug Development Research Collaboration with Georgetown...
Daniel Carlson
-
October 5, 2020
0
Front Page
LexaGene Provides a Corporate Update
Daniel Carlson
-
October 5, 2020
0
Anixa
The Final Push…
Daniel Carlson
-
October 2, 2020
3
Front Page
Muscle Maker Grill Opens Their Second College Campus Location in Virginia
Daniel Carlson
-
October 1, 2020
0
Front Page
Trade Alert, October 1, 2020
Daniel Carlson
-
October 1, 2020
3
Front Page
Provention Bio Files Clinical Module for Teplizumab for the Delay or...
Daniel Carlson
-
October 1, 2020
0
Fortress Bio
Mustang Bio Announces First Patient Dosed in Multicenter Phase 1/2 Clinical...
Daniel Carlson
-
October 1, 2020
0
Cabral Gold
Cabral Gold Reports Channel Sample Results of 5.3m @ 24.0 g/t...
Daniel Carlson
-
September 30, 2020
0
Front Page
WiSA Introduces SoundSend Home Cinema Audio Transmitter to Instantly Connect 100’s...
Daniel Carlson
-
September 29, 2020
0
Front Page
Making Our Case For ParkerVision
Daniel Carlson
-
September 28, 2020
2
Front Page
ParkerVision Files Against Hisense for Patent Infringement
Daniel Carlson
-
September 28, 2020
0
Cabral Gold
Wrapping Up A Chaotic Week
Daniel Carlson
-
September 26, 2020
0
Dyadic
Dyadic and VTT Are Developing an Efficient New Production Method for...
Daniel Carlson
-
September 24, 2020
0
Front Page
Muscle Maker Grill Opens Their First of Four College Campus Locations...
Daniel Carlson
-
September 24, 2020
0
Cabral Gold
Cabral Gold Identifies New High-Grade Veins and Adds Second Drill Rig...
Daniel Carlson
-
September 24, 2020
0
Front Page
TFF Pharmaceuticals Comments on Animal Studies in the Development of High...
Daniel Carlson
-
September 24, 2020
0
Front Page
World’s First WiSA Ready™ 4K UHD Smart Projector Developed by LG...
Daniel Carlson
-
September 22, 2020
0
Anixa
Anixa’s Breast Cancer Vaccine; A Conversation With Dr. Vince Tuohy
Daniel Carlson
-
September 22, 2020
0
Front Page
Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer...
Daniel Carlson
-
September 22, 2020
0
Front Page
LexaGene’s CEO Provides Video Message on Company’s Progress and Announces Appointment...
Daniel Carlson
-
September 21, 2020
2
Anixa
West Bound and Down
Daniel Carlson
-
September 19, 2020
0
Fortress Bio
Checkpoint Therapeutics Announces Positive Interim Results from Registration-Enabling Trial of Cosibelimab...
Daniel Carlson
-
September 17, 2020
0
Dyadic
Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug...
Daniel Carlson
-
September 17, 2020
0
Front Page
LexaGene’s Covid-19 Diagnostic Readies For The FDA
Daniel Carlson
-
September 17, 2020
17
Front Page
Muscle Maker Grill Ghosting NYC With Two New Ghost Kitchens
Daniel Carlson
-
September 16, 2020
0
Front Page
INmune Bio, Inc. Awarded $2.9 Million NIH Small Business Innovation Research...
Daniel Carlson
-
September 16, 2020
0
Front Page
TFF Pharmaceuticals Announces Topline Results of Voriconazole Inhalation Powder Phase 1...
Daniel Carlson
-
September 15, 2020
0
Fortress Bio
Fortress Biotech Announces Initiation of Phase 3 Studies of CAEL-101 in...
Daniel Carlson
-
September 14, 2020
0
Anixa
Under The Radar…Key Data-Points From The Last Week That Nobody Really...
Daniel Carlson
-
September 12, 2020
2
Front Page
Muscle Maker Grill Announces Pricing of $5.6 Million Follow-On Public Offering...
Daniel Carlson
-
September 11, 2020
0
Fortress Bio
Avenue Therapeutics Announces Publication of a Review of IV Tramadol
Daniel Carlson
-
September 9, 2020
0
Catasys
Ontrak Announces Full Exercise of Overallotment Option in Public Offering of...
Daniel Carlson
-
September 8, 2020
0
Atomera
Hello Fall!
Daniel Carlson
-
September 4, 2020
11
Front Page
INmune Bio, Inc. Announces Issuance of Patent from U.S. Patent &...
Daniel Carlson
-
September 3, 2020
0
Anixa
Is It Finally Time For Anixa to Shine?
Daniel Carlson
-
September 3, 2020
1
Front Page
What’s Next for TFF?
Daniel Carlson
-
September 3, 2020
2
Fortress Bio
Mustang Bio Announces Orphan Drug Designation for MB-107 for the Treatment...
Daniel Carlson
-
September 2, 2020
0
Front Page
INmune Bio, Inc. Announces FDA Acceptance of IND Application to Evaluate...
Daniel Carlson
-
September 1, 2020
0
Fortress Bio
Mustang Bio Announces Rare Pediatric Disease Designation for MB-207 for the...
Daniel Carlson
-
August 31, 2020
0
Anixa
Goodbye August (almost)…
Daniel Carlson
-
August 29, 2020
1
Fortress Bio
Fortress Biotech Announces Positive Topline Clinical Efficacy Results for CUTX-101, Copper...
Daniel Carlson
-
August 28, 2020
0
Fortress Bio
Fortress Biotech Announces $60 Million Loan Agreement with Oaktree Capital Management
Daniel Carlson
-
August 28, 2020
0
Front Page
Muscle Maker Grill Adds Two Locations in Philadelphia to Their Growing...
Daniel Carlson
-
August 27, 2020
0
Lantern
Lantern Pharma Announces Upcoming Conference Presentations
Daniel Carlson
-
August 27, 2020
0
Front Page
Trading Blog, August 26th
Daniel Carlson
-
August 26, 2020
2
Front Page
WiSA Member SKYWORTH Launches Metz Sculpture 1 TV and Speakers Featuring...
Daniel Carlson
-
August 25, 2020
0
Catasys
Ontrak Announces Public Offering of Non-Convertible Perpetual Preferred Stock
Daniel Carlson
-
August 22, 2020
0
Front Page
Trading Blog, August 21st
Daniel Carlson
-
August 21, 2020
2
Fortress Bio
Mustang Bio Announces Rare Pediatric Disease Designation for MB-107 for the...
Daniel Carlson
-
August 17, 2020
0
Anixa
This Week at Tailwinds
Daniel Carlson
-
August 15, 2020
1
Dyadic
Dyadic Announces Second Quarter 2020 Results and Highlights Recent Company Progress
Daniel Carlson
-
August 14, 2020
0
Front Page
TFFP: The Tip Of The Iceberg
Daniel Carlson
-
August 14, 2020
3
Front Page
Summit Wireless Technologies Provides Second Quarter 2020 Update
Daniel Carlson
-
August 13, 2020
0
Front Page
TFF Pharmaceuticals Enters into Worldwide Licensing Agreement with UNION therapeutics for...
Daniel Carlson
-
August 13, 2020
0
Front Page
mCloud Announces Second Quarter 2020 Financial Results
Daniel Carlson
-
August 13, 2020
0
Front Page
WiSA Launches the WiSA Wave Marketing Program to Drive Category Sales
Daniel Carlson
-
August 13, 2020
0
Front Page
European Patent Granted Covering INmune Bio’s XPro1595
Daniel Carlson
-
August 13, 2020
0
Anixa
Anixa and OntoChem Announce Identification of Additional Covid-19 Compounds
Daniel Carlson
-
August 13, 2020
0
Front Page
MTBC Reports Second Quarter 2020 Results, Reaffirms Guidance
Daniel Carlson
-
August 13, 2020
0
Front Page
Muscle Maker Grill Begins Construction at Four Northern Virginia Community College...
Daniel Carlson
-
August 12, 2020
0
Fortress Bio
Fortress Biotech Announces Virtual Two-Day Corporate Access Summit Hosted by B....
Daniel Carlson
-
August 12, 2020
0
Front Page
TFF Pharmaceuticals Announces $25.9 Million in Financing to Further Advance Its...
Daniel Carlson
-
August 11, 2020
0
Fortress Bio
Fortress Biotech Reports Second Quarter 2020 Financial Results and Recent Corporate...
Daniel Carlson
-
August 10, 2020
4
Front Page
Harrow Reports 2nd Quarter Earnings
Daniel Carlson
-
August 10, 2020
0
Anixa
OnTrak For A Great Year
Daniel Carlson
-
August 8, 2020
11
Front Page
INmune Earnings Conference Call Transcript
Daniel Carlson
-
August 7, 2020
0
Front Page
Provention Bio Reports Second Quarter 2020 Financial Results and Provides Business...
Daniel Carlson
-
August 6, 2020
0
Catasys
Ontrak Announces 2020 Second Quarter Financial Results
Daniel Carlson
-
August 6, 2020
0
Atomera
Atomera Provides Second Quarter 2020 Results
Daniel Carlson
-
August 6, 2020
0
Front Page
EyePoint Pharmaceuticals and Harrow Health’s ImprimisRx Announce U.S. Commercial Alliance for...
Daniel Carlson
-
August 4, 2020
0
Front Page
QUEST RESOURCE HOLDING CORPORATION REPORTS PRELIMINARY SECOND QUARTER RESULTS
Daniel Carlson
-
August 4, 2020
0
Front Page
Monaker Alternative Lodging Inventory goes live on Agoda Through RateGain Connection
Daniel Carlson
-
August 4, 2020
0
Front Page
WiSA, Wireless Speaker and Audio Association, Shows Tremendous Growth in Consumer...
Daniel Carlson
-
August 3, 2020
0
Front Page
INmune Bio, Inc to Present at the BTIG Virtual Biotechnology Conference...
Daniel Carlson
-
August 3, 2020
0
Front Page
July Recap, August Preview…Best Month Yet at Tailwinds
Daniel Carlson
-
August 1, 2020
2
Catasys
Ontrak, Inc. achieves HITRUST CSF® Certification to Further Mitigate Risk in...
Daniel Carlson
-
July 31, 2020
0
Front Page
Muscle Maker Grill Opens First of Five Delivery-Only Ghost Kitchens in...
Daniel Carlson
-
July 30, 2020
0
Front Page
TFF Pharmaceuticals Announces Completion of Dosing for Voriconazole Inhalation Powder Phase...
Daniel Carlson
-
July 30, 2020
0
Lantern
Lantern Pharma Reports Second Quarter 2020 Financial Results and Continued Corporate...
Daniel Carlson
-
July 30, 2020
0
Front Page
Monaker Group Launches Instantly Confirmed Vacation Rentals on Maupintour.com as it...
Daniel Carlson
-
July 29, 2020
0
Front Page
TFF Pharmaceuticals Comments on Research on the Re-formulation of Remdesivir to...
Daniel Carlson
-
July 29, 2020
0
Front Page
Sequans Communications Announces Second Quarter 2020 Financial Results
Daniel Carlson
-
July 28, 2020
0
Anixa
Anixa Biosciences Breast Cancer Vaccine Technology Nearing FDA Submission
Daniel Carlson
-
July 28, 2020
0
Front Page
TFFP Applies Thin Film Freezing to Remdesivir with Outstanding Results
Daniel Carlson
-
July 28, 2020
0
Fortress Bio
Checkpoint Therapeutics to Present Cosibelimab Interim Results from Registration-Enabling Trial at...
Daniel Carlson
-
July 27, 2020
0
Front Page
MTBC Provides 1H 2020 Update and Discusses Full-Year Outlook
Daniel Carlson
-
July 27, 2020
0
Anixa
Random Thoughts on a Number of Stocks…
Daniel Carlson
-
July 24, 2020
2
Front Page
Monaker Group Announces Pricing of $2.0 Million Registered Direct Offering
Daniel Carlson
-
July 24, 2020
0
Front Page
MONAKER GROUP ENTERS INTO AGREEMENT TO ACQUIRE TECHNOLOGY LEADER HOTPLAY AND...
Daniel Carlson
-
July 23, 2020
2
Front Page
SKYWORTH Continues to Lead the TV Industry by Joining the WiSA...
Daniel Carlson
-
July 22, 2020
0
Fortress Bio
Avenue Therapeutics Announces Publication of Phase 3 Bunionectomy Study Results
Daniel Carlson
-
July 21, 2020
0
Front Page
This Week at Tailwinds
Daniel Carlson
-
July 18, 2020
17
Front Page
INmune Bio, Inc. Prices Public Offering of Common Stock
Daniel Carlson
-
July 16, 2020
0
Front Page
MTBC Announces Commencement of Public Offering of Preferred Stock
Daniel Carlson
-
July 16, 2020
0
Front Page
INMB’s XPro1595…A Potential Disease Modifying Therapy for Alzheimer’s
Daniel Carlson
-
July 16, 2020
0
Dyadic
Dyadic International Announces Fully Funded Human Health R&D Collaboration with a...
Daniel Carlson
-
July 15, 2020
0
Front Page
INmune Bio, Inc. Announces Interim Phase Ib Data Demonstrating That XPro1595...
Daniel Carlson
-
July 13, 2020
0
Front Page
Leading Peer-Reviewed Journal Publishes Clinical Study on ImprimisRx’s Combination Prescription Eyedrops
Daniel Carlson
-
July 13, 2020
0
Anixa
Anixa Biosciences’ CAR-T Cancer Therapy Receives Intention to Grant Notice from...
Daniel Carlson
-
July 10, 2020
1
Front Page
Bienestar Health Group Chooses MTBC to Deliver Integrated EHR and Telehealth...
Daniel Carlson
-
July 9, 2020
0
Front Page
Muscle Maker Grill Signs Lease to Expand at Texas Tech University...
Daniel Carlson
-
July 9, 2020
0
Front Page
INmune Bio, Inc. to Announce Interim Data from Phase Ib Clinical...
Daniel Carlson
-
July 9, 2020
0
Dyadic
Dyadic Announces Two New Fully Funded Collaborations with Leading Global Animal...
Daniel Carlson
-
July 8, 2020
0
Front Page
MTBC Increases Revenue Guidance
Daniel Carlson
-
July 7, 2020
0
Catasys
Catasys, Inc. is now Ontrak, Inc.
Daniel Carlson
-
July 6, 2020
0
Anixa
Anixa and OntoChem Announce Completion of Initial Screening Program and Identification...
Daniel Carlson
-
July 6, 2020
2
Anixa
Happy 4th of July…A Review of June and Other Notes
Daniel Carlson
-
July 2, 2020
0
Anixa
Anixa Announces Strategic Program Realignment Focused on Advancement of its Therapeutic...
Daniel Carlson
-
July 2, 2020
3
Catasys
Catasys Announces National Rollout…Here’s What’s Next
Daniel Carlson
-
July 1, 2020
0
Catasys
National Health Plan Expands Catasys’ OnTrak-CI Program Across Their National Medicare...
Daniel Carlson
-
June 30, 2020
0
Front Page
TFF Pharmaceuticals Announces First Human Dosing With Tacrolimus Inhalation Powder and...
Daniel Carlson
-
June 29, 2020
0
Front Page
This Week at Tailwinds
Daniel Carlson
-
June 26, 2020
1
Front Page
Muscle Maker Grill Pilots Expanded Burger Menu & New Concept Name...
Daniel Carlson
-
June 25, 2020
0
Front Page
ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of...
Daniel Carlson
-
June 23, 2020
0
Front Page
Summit Wireless Technologies Appoints Sri Peruvemba, Global Marketing Expert, to the...
Daniel Carlson
-
June 22, 2020
0
Anixa
Summer is Coming
Daniel Carlson
-
June 20, 2020
1
Front Page
Trading Update, June 19, 2020
Daniel Carlson
-
June 19, 2020
4
Front Page
Envision Pain Management Selects MTBC’s CareCloud to Support Operational Growth
Daniel Carlson
-
June 19, 2020
2
Front Page
TFF Pharmaceuticals Receives Orphan Drug Designation for Tacrolimus Inhalation Powder
Daniel Carlson
-
June 18, 2020
0
Front Page
Fauci Driving Dyadic (Nasdaq: DYAI) Towards the Goal Line…
Daniel Carlson
-
June 17, 2020
0
Front Page
MTBC Acquires Meridian Medical Management, a Former GE Healthcare IT Company
Daniel Carlson
-
June 17, 2020
0
Front Page
HyreCar Provides Corporate Update and New Insurance Partnership with Lloyd’s Apollo...
Daniel Carlson
-
June 16, 2020
0
Front Page
Highly Accomplished Executives Join BioVie’s Board of Directors
Daniel Carlson
-
June 16, 2020
0
Front Page
Provention Bio’s Teplizumab Continued to Significantly Delay the Onset of Insulin-Dependent...
Daniel Carlson
-
June 15, 2020
0
Anixa
This Week at Tailwinds…Scratching My Head
Daniel Carlson
-
June 13, 2020
1
Front Page
BioVie Advances the BIV201 Clinical Program and Prefilled Syringe
Daniel Carlson
-
June 11, 2020
0
Front Page
Muscle Maker Grill Begins Construction on Third and Fourth Delivery-Only Ghost...
Daniel Carlson
-
June 11, 2020
0
Fortress Bio
Mustang Bio Announces Pricing of Public Offering of Common Stock
Daniel Carlson
-
June 11, 2020
0
Front Page
INmune Bio, Inc. Receives Regulatory Approval from UK MHRA to Initiate...
Daniel Carlson
-
June 11, 2020
0
Front Page
Summit Wireless Technologies Announces Pricing of $5.3 Million Registered Direct Offering...
Daniel Carlson
-
June 10, 2020
0
Front Page
WiSA Welcomes Buchardt Audio as a New Member and Certifies the...
Daniel Carlson
-
June 9, 2020
0
Front Page
Muscle Maker Grill expands team with Vice President of Real Estate...
Daniel Carlson
-
June 8, 2020
0
Front Page
ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical...
Daniel Carlson
-
June 8, 2020
0
Atomera
Three Disruptive Plays…And Other Thoughts From Last Week
Daniel Carlson
-
June 6, 2020
3
Fortress Bio
Avenue Therapeutics Announces Publications in Peer-Reviewed Journals
Daniel Carlson
-
June 5, 2020
0
Front Page
Revisiting Endra…Has Their Time Arrived?
Daniel Carlson
-
June 4, 2020
0
Front Page
Summit Wireless Technologies Announces Pricing of $5.8 Million Registered Direct Offering...
Daniel Carlson
-
June 4, 2020
0
Front Page
First-of-Its-Kind Human Tissue Study Finds Link Between NAD Decline and Alcohol-Related...
Daniel Carlson
-
June 3, 2020
1
Front Page
WiSA Certifies 2020 LG Electronics 8K OLED and LG NanoCell TVs...
Daniel Carlson
-
June 3, 2020
0
Front Page
WiSA Certifies Axiim WM Speaker Series
Daniel Carlson
-
June 1, 2020
0
Uncategorized
Muscle Maker Grill to open four locations at Northern Virginia Community...
Daniel Carlson
-
June 1, 2020
0
Uncategorized
Hancock Jaffe Announces Intention to Merge with Catheter Precision
Daniel Carlson
-
June 1, 2020
2
Front Page
Exscribe Orthopaedic Healthcare Solutions Selects MTBC Force
Daniel Carlson
-
June 1, 2020
0
Anixa
Anixa Biosciences and OntoChem Have Synthesized Four Potential Covid-19 Drugs for...
Daniel Carlson
-
June 1, 2020
0
Front Page
ParkerVision’s Day In Court Coming Soon (Executive Summary)
Daniel Carlson
-
May 28, 2020
0
Front Page
Summit Wireless Technologies Provides First Quarter 2020 Update
Daniel Carlson
-
May 27, 2020
0
Fortress Bio
Moneyball for Biotech
Daniel Carlson
-
May 26, 2020
2
Front Page
Monaker Hires Randy Laser as VP, Products and Revenue Management
Daniel Carlson
-
May 19, 2020
0
Front Page
Killers at the Crossroad – A Published Review of Innate Immune...
Daniel Carlson
-
May 19, 2020
0
Front Page
Provention Bio and Vactech Announce Publication of Proof-of-Concept Data for a...
Daniel Carlson
-
May 18, 2020
0
Anixa
Bada Bing Bada Boom
Daniel Carlson
-
May 16, 2020
1
Front Page
ParkerVision Files Against TCL for Patent Infringement
Daniel Carlson
-
May 15, 2020
0
Front Page
HyreCar Announces First Quarter 2020 Results
Daniel Carlson
-
May 14, 2020
0
Front Page
QUEST RESOURCE HOLDING REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS
Daniel Carlson
-
May 14, 2020
0
Front Page
TFF Pharmaceuticals Reports First Quarter 2020 Financial and Business Results
Daniel Carlson
-
May 14, 2020
0
Front Page
MTBC Reports Record First Quarter 2020 Revenue
Daniel Carlson
-
May 14, 2020
0
Front Page
INmune Bio, Inc. Announces First Quarter 2020 Results and Provides Business...
Daniel Carlson
-
May 14, 2020
0
Front Page
Monaker Launches new Maupintour.com Website, Re-energizes Historic Travel Brand
Daniel Carlson
-
May 13, 2020
0
Atomera
Atomera Inc. Prices Underwritten Public Offering of Common Stock
Daniel Carlson
-
May 13, 2020
6
Front Page
Hancock Jaffe Announces Plans for CoreoGraft First-in-Human Study
Daniel Carlson
-
May 12, 2020
0
Catasys
Catasys Expands OnTrak-A Solution with Leading National Health Plan into Arizona
Daniel Carlson
-
May 12, 2020
0
Front Page
ChromaDex Corporation Reports First Quarter 2020 Financial Results
Daniel Carlson
-
May 11, 2020
0
Front Page
Harrow Health, Inc. Letter to Stockholders
Daniel Carlson
-
May 11, 2020
0
Fortress Bio
Fortress Biotech Reports Record First Quarter 2020 Financial Results and Recent...
Daniel Carlson
-
May 11, 2020
0
Front Page
Is HYRE a Buy Before Earnings?
Daniel Carlson
-
May 11, 2020
0
Front Page
INmune Bio Inc’s INB03 Inhibits Cell Migration, Tumor Growth, and Induces...
Daniel Carlson
-
May 11, 2020
0
Anixa
The Week In Review
Daniel Carlson
-
May 9, 2020
3
Front Page
Trade Alert, May 8, 2020
Daniel Carlson
-
May 8, 2020
0
Fortress Bio
Fortress Biotech Announces Exclusive Worldwide License Agreement With Columbia University to...
Daniel Carlson
-
May 8, 2020
0
Front Page
Eton Pharmaceuticals Confirms First-to-File Patent Challenge on Elcys (Cysteine Hydrochloride Injection)
Daniel Carlson
-
May 7, 2020
0
Catasys
Catasys Announces 2020 First Quarter Financial Results
Daniel Carlson
-
May 7, 2020
0
Front Page
Provention Bio Reports First Quarter 2020 Financial Results and Provides Business...
Daniel Carlson
-
May 7, 2020
0
Front Page
RESONANT INC. REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS
Daniel Carlson
-
May 6, 2020
0
Fortress Bio
Checkpoint Therapeutics Reports First Quarter 2020 Financial Results and Recent Corporate...
Daniel Carlson
-
May 6, 2020
0
Front Page
Muscle Maker Grill Breaks Ground on Two Delivery-Only Ghost Kitchens in...
Daniel Carlson
-
May 6, 2020
0
Front Page
MDS Medical Selects MTBC Force as RCM Services Partner
Daniel Carlson
-
May 5, 2020
0
Atomera
Atomera Conference Call Transcript
Daniel Carlson
-
May 4, 2020
0
Anixa
Anixa Biosciences and OntoChem Announce Discovery of First Covid-19 Therapeutic Candidate
Daniel Carlson
-
May 4, 2020
0
Anixa
The Eye Of The Storm…This Week In Tailwinds’ World
Daniel Carlson
-
May 2, 2020
4
Front Page
Patriot One Update Call With Martin Cronin
Daniel Carlson
-
May 1, 2020
9
Atomera
Atomera Provides First Quarter 2020 Results
Daniel Carlson
-
April 30, 2020
0
Front Page
ParkerVision Receives Favorable Markman Order in Patent Infringement Action Against Qualcomm...
Daniel Carlson
-
April 30, 2020
0
Front Page
TFF Pharmaceuticals’ Inventor Dr. Robert O. Williams III Presents Session on...
Daniel Carlson
-
April 30, 2020
0
Front Page
Hancock Jaffe Announces One Year Follow-up Data on VenoValve Patients
Daniel Carlson
-
April 28, 2020
0
Front Page
MTBC Completes Its Offering of Non-Convertible Preferred Stock with $20.7 Million...
Daniel Carlson
-
April 27, 2020
0
Anixa
Anixa and INmune: Unique COVID-19 Opportunities In Tailwinds’ Universe
Daniel Carlson
-
April 27, 2020
0
Front Page
Hancock Jaffe Announces Registered Direct Offering
Daniel Carlson
-
April 27, 2020
0
Anixa
This Week in Stocks
Daniel Carlson
-
April 25, 2020
4
Front Page
Vicor Corporation Reports Results for the First Quarter Ended March 31,...
Daniel Carlson
-
April 23, 2020
0
Fortress Bio
Avenue Therapeutics Announces Presentation of IV Tramadol E-Posters
Daniel Carlson
-
April 23, 2020
0
Anixa
Anixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Biomarker Insights...
Daniel Carlson
-
April 23, 2020
0
Front Page
Frontiers in Oncology Publishes an Invited Review Highlighting Soluble TNF’s Impact...
Daniel Carlson
-
April 23, 2020
0
Front Page
Akazoo Announces Formation of Independent Special Committee
Daniel Carlson
-
April 22, 2020
0
Front Page
INmune Bio Announces Allowance of U.S. Patent Covering Method for Treating...
Daniel Carlson
-
April 22, 2020
0
Front Page
INmune Bio (INMD) Conference Call on COVID19 Program Transcript
Daniel Carlson
-
April 21, 2020
0
Front Page
Summit Wireless Technologies Announces Pricing of $6.5 Million Underwritten Public Offering
Daniel Carlson
-
April 21, 2020
0
Front Page
INmune Addresses COVID-19
Daniel Carlson
-
April 20, 2020
0
Front Page
ChromaDex Commits to COVID-19 Research Following Promising Initial Preclinical Findings Showing...
Daniel Carlson
-
April 20, 2020
0
Front Page
INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF...
Daniel Carlson
-
April 20, 2020
0
Fortress Bio
Mustang Bio Receives Advanced Therapy Medicinal Product Classification from European Medicines...
Daniel Carlson
-
April 20, 2020
0
Anixa
Anixa Biosciences and OntoChem Announce Collaboration to Develop Novel COVID-19 Therapeutics
Daniel Carlson
-
April 20, 2020
0
Fortress Bio
Saturday Morning Ramblings…
Daniel Carlson
-
April 18, 2020
3
Front Page
Provention Bio Initiates Rolling Submission of Biologic License Application for Teplizumab...
Daniel Carlson
-
April 16, 2020
0
Front Page
Muscle Maker Grill Launches Grocery Service to Provide Essentials and Support...
Daniel Carlson
-
April 15, 2020
1
Front Page
TFF Pharmaceuticals Announces Cooperative Research and Development Agreement (CRADA) with the...
Daniel Carlson
-
April 15, 2020
0
Front Page
Titan Health Management Solutions Selects MTBC Force to Expand RCM Services...
Daniel Carlson
-
April 14, 2020
0
Front Page
RESONANT INC. EXPANDS XBAR® PERFORMANCE TO ADDRESS 5G-WI-FI CO-EXISTENCE ISSUES
Daniel Carlson
-
April 14, 2020
0
Front Page
MTBC Reaffirms 2020 Guidance
Daniel Carlson
-
April 9, 2020
0
Front Page
Summit Wireless Technologies Announces 1-for-20 Reverse Stock Split
Daniel Carlson
-
April 8, 2020
0
Catasys
Catasys Expands OnTrak-A Solution with Leading National Health Plan into Indiana,...
Daniel Carlson
-
April 7, 2020
1
Front Page
HyreCar Provides Business Update and Indication of First Quarter 2020 Revenue
Daniel Carlson
-
April 6, 2020
0
Anixa
IF Alpha?
Daniel Carlson
-
April 4, 2020
1
Front Page
Trading Update, April 3, 2020
Daniel Carlson
-
April 3, 2020
0
Fortress Bio
Building Our Case for Fortress (FBIO)
Daniel Carlson
-
April 2, 2020
0
Front Page
MTBC Announces Marketing and Sales Leadership to Accelerate Market Expansion and...
Daniel Carlson
-
April 1, 2020
0
Front Page
WiSA Announces Certification of the Harman Kardon Citation Sub S
Daniel Carlson
-
March 31, 2020
0
Front Page
Muscle Maker Grill Continues Brand Expansion Efforts With New Location at...
Daniel Carlson
-
March 30, 2020
0
Anixa
Take a Deep Breath…Updates on the Market and Several Stocks
Daniel Carlson
-
March 27, 2020
3
Front Page
HyreCar Could Emerge From CV19 A Stronger Player
Daniel Carlson
-
March 27, 2020
5
Front Page
TFF Pharmaceuticals Reports Fourth Quarter Results and Full Year 2019 Financial...
Daniel Carlson
-
March 26, 2020
0
Front Page
HyreCar Announces Fourth Quarter and Full-Year 2019 Results
Daniel Carlson
-
March 26, 2020
2
Front Page
Summit Wireless Technologies Provides Fourth Quarter Update
Daniel Carlson
-
March 25, 2020
0
Catasys
Catasys’ Telehealth-Enabled OnTrak™ Programs See Surge in Enrollment and Engagement Amidst...
Daniel Carlson
-
March 25, 2020
0
Front Page
ImprimisRx® Announces Exclusive Agreement with Doxy.me to Provide Healthcare Professionals with...
Daniel Carlson
-
March 24, 2020
0
Front Page
Muscle Maker Grill – Delivery Operation Ramp Up and Operating Update...
Daniel Carlson
-
March 24, 2020
0
Front Page
Summit Wireless Raises $1.7M in Private Placement of a Senior Secured...
Daniel Carlson
-
March 23, 2020
2
Catasys
There’s Blood In The Streets…
Daniel Carlson
-
March 21, 2020
4
Front Page
TFF Pharmaceuticals Announces Phase 1 Clinical Trial Progress for Voriconazole Inhalation...
Daniel Carlson
-
March 19, 2020
0
Front Page
Muscle Maker Grill to Focus on Delivery & Boosts Guest Morale...
Daniel Carlson
-
March 18, 2020
0
Front Page
Akazoo Announces Share Repurchase Program and Special and Extraordinary General Meeting...
Daniel Carlson
-
March 18, 2020
0
Catasys
Brandon H. LaVerne Joins Catasys as Chief Financial Officer
Daniel Carlson
-
March 17, 2020
0
Fortress Bio
Fortress Biotech Reports Record Fourth Quarter and Full-Year 2019 Financial Results...
Daniel Carlson
-
March 16, 2020
0
Front Page
WiSA Certifies Center Channel and On-Wall Speaker Solutions from System Audio
Daniel Carlson
-
March 16, 2020
0
Front Page
HyreCar Inc. to Announce Fourth Quarter and Full Year 2019 Results...
Daniel Carlson
-
March 13, 2020
0
Catasys
Catasys Announces 2019 Fourth Quarter Financial and Year-end Financial Results
Daniel Carlson
-
March 13, 2020
0
Front Page
Harrow Health Publishes Fourth Quarter 2019 Letter to Stockholders
Daniel Carlson
-
March 13, 2020
0
Front Page
QUEST RESOURCE HOLDING CORPORATION REPORTS 2019 FINANCIAL RESULTS
Daniel Carlson
-
March 12, 2020
0
Front Page
Harrow Gaining Traction…
Daniel Carlson
-
March 12, 2020
0
Front Page
INMB: INmune Bio Earnings Call Transcript
Daniel Carlson
-
March 12, 2020
0
Front Page
TFF Pharmaceuticals Announces Engagement of J.S. Cole & Associates as Strategic...
Daniel Carlson
-
March 12, 2020
0
Front Page
Provention Announces Positive Data from Phase 1b PREVAIL Study of PRV-3279
Daniel Carlson
-
March 12, 2020
0
Fortress Bio
Checkpoint Therapeutics Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
Daniel Carlson
-
March 11, 2020
0
Front Page
Muscle Maker Grill Announces New Military Veteran Franchise Program
Daniel Carlson
-
March 11, 2020
2
Catasys
Catasys Announces 2019 Fourth Quarter Financial and Year-end Financial Results
Daniel Carlson
-
March 11, 2020
0
Front Page
WiSA Announces Support of Dolby Atmos Height Channels
Daniel Carlson
-
March 10, 2020
0
Front Page
ImprimisRx® Announces Supply Agreement with iOR Partners
Daniel Carlson
-
March 9, 2020
0
Front Page
TFF Pharmaceuticals Announces Engagement of Torreya Partners, LLC as Strategic Advisor...
Daniel Carlson
-
March 9, 2020
0
Front Page
Earnings For Tailwinds Kicks In, Plus The Week In Review
Daniel Carlson
-
March 7, 2020
0
Anixa
Anixa: an Update on Their Breast Cancer Vaccine Program
Daniel Carlson
-
March 6, 2020
1
Front Page
I Cast My Vote This Week…For SONG
Daniel Carlson
-
March 5, 2020
0
Front Page
WiSA Announces 4 New Members
Daniel Carlson
-
March 5, 2020
2
Front Page
Principal Investigator Dr. Jorge Hernando Ulloa Presents Updated VenoValve Data at...
Daniel Carlson
-
March 5, 2020
2
Front Page
ImprimisRx® Announces Supply Agreement with Vision Center Network of America (VCNA)
Daniel Carlson
-
March 3, 2020
0
Catasys
Brian Kelly, President of Clinical Healthcare Solutions at Ascend Learning, Joins...
Daniel Carlson
-
March 3, 2020
0
Front Page
Muscle Maker Grill expands growth with 6th military location to open...
Daniel Carlson
-
March 3, 2020
0
Front Page
Muscle Maker Ready to Flex
Daniel Carlson
-
March 2, 2020
0
Anixa
Anixa Biosciences Announces Presentation at AI and Big Data in Cancer...
Daniel Carlson
-
March 2, 2020
2
Front Page
MOAS Version 0.96b
Daniel Carlson
-
February 29, 2020
0
Front Page
MTBC Reports Record Full Year 2019 Results
Daniel Carlson
-
February 28, 2020
2
Front Page
Vicor Offers Investors Another Chance To Catch The Tide
Daniel Carlson
-
February 27, 2020
0
Front Page
Muscle Maker Grill Signs Agreement with Major Industry Leading Delivery-Only Kitchen...
Daniel Carlson
-
February 27, 2020
0
Catasys
Catasys Expands OnTrak-A Solution with Leading National Health Plan into Colorado,...
Daniel Carlson
-
February 27, 2020
0
Front Page
INMB: Interview with Dr. CJ Barnum, Director of Neuroscience
Daniel Carlson
-
February 26, 2020
0
Front Page
Consumer Interest Increases in WiSA Products
Daniel Carlson
-
February 26, 2020
4
Front Page
Hancock Jaffe Principal Investigator Dr. Jorge Hernando Ulloa to Present Updated...
Daniel Carlson
-
February 26, 2020
0
Front Page
MUSCLE MAKER, INC RELEASES THE KETO YOUR WAY MENU
Daniel Carlson
-
February 25, 2020
0
Front Page
Dyadic and The Israel Institute for Biological Research (IIBR) Expand...
Daniel Carlson
-
February 25, 2020
0
Front Page
Akazoo Announces Special and Extraordinary Shareholder Meetings
Daniel Carlson
-
February 25, 2020
0
Atomera
Thoughts From Last Week
Daniel Carlson
-
February 22, 2020
8
Front Page
MTBC Announces Telehealth Division, Appoints Leadership Team to Drive Growth
Daniel Carlson
-
February 20, 2020
0
Front Page
Eton Pharmaceuticals Provides Update on ET-105 Program
Daniel Carlson
-
February 19, 2020
0
Front Page
NJ Spine and Wellness Selects MTBC’s CareCloud Solution
Daniel Carlson
-
February 18, 2020
0
Fortress Bio
Mustang Bio Announces First Subject Treated in Phase 1/2 Trial with...
Daniel Carlson
-
February 18, 2020
0
Anixa
Thoughts From The Last Week…
Daniel Carlson
-
February 15, 2020
7
Muscle Maker
Muscle Maker Grill Announces Pricing of $7.7 Million Initial Public Offering
Daniel Carlson
-
February 13, 2020
0
Atomera
ATOM: Our Read on the Investor Update Call
Daniel Carlson
-
February 13, 2020
0
Fortress Bio
Avenue Therapeutics Announces New Drug Application for IV Tramadol Accepted for...
Daniel Carlson
-
February 13, 2020
0
Front Page
Monaker Group Invited to Speak at the RateGain Future Connect Summit...
Daniel Carlson
-
February 13, 2020
0
Atomera
Atomera Provides Fourth Quarter and Fiscal 2019 Results
Daniel Carlson
-
February 12, 2020
0
Uncategorized
ParkerVision Files Against Intel for Patent Infringement
Daniel Carlson
-
February 12, 2020
0
Front Page
INmune Webinar Transcript: Bench to Bedside
Daniel Carlson
-
February 12, 2020
0
Front Page
ChromaDex Partners with Personalized Nutrition Company, Persona Nutrition, Expanding Global Partnership...
Daniel Carlson
-
February 12, 2020
0